Birbarah, C., Tebache, L., Brichant, G. and Nisolle, M. (2021) What Is the Place of Surgery of Deep Endometriosis in Infertile and Pelvic Pain Patients? In: Genazzani, A.R., Nisolle, M., Petraglia, F. and Taylor, R.N., Eds., Endometriosis Pathogenesis, Clinical Impact and Management, Springer, Cham, 83-95.
https://doi.org/10.1007/978-3-030-57866-4_9

has been cited by the following article:

• TITLE: Sclerotherapy with Leuprolide and Cefoperazone Sulbactam in the Management of Ovarian Endometriomas under Ultrasound Guidance: A Novel Approach

  AUTHORS: Yazhini Selvaraj

  KEYWORDS: Ovarian Endometriomas (OE), Infertility (IF), Sclerosing Agent (SA), Leuprolide with Cefoperazone Sulbactam (LCS), In Vitro Fertilization (IVF)

  JOURNAL NAME: Advances in Sexual Medicine, Vol.12 No.1, January 5, 2022

  ABSTRACT: Endometriosis is an estrogen dependent gynecological disorder, which can occur throughout the reproductive age of women, causing chronic pelvic pain, substantial morbidity, and impaired fertility. It is clinically defined as the presence of ectopic endometrium resulting in sustained inflammatory reaction. In India, about 29,000,000 women suffer from endometriosis. Severe pelvic pain and recurrent endometriomas were observed even after surgery. We have conducted aspirations totally in 110 patients in which most of the patients were suffering from Stage III & Stage IV of endometriosis except for 7 patients for whom we have done as primary therapy for endometriomas. Among 110 patients, 4 patients didn’t turn up for follow up after first aspiration. This pilot study conducted with 110 patients in Ponni Hospital and Fertility Research Centre, Madurai aimed to evaluate pregnancy outcome in 51 infertile patients, and to alleviate pelvic pain, to restore a healthy sexual life and to reduce the recurrence rate of Ovarian Endometriomas (OE) in 59 patients, who did not seek fertility, After using the newer sclerosing agent Leuprolide with Cefoperazone Sulbactam (LCS) under ultrasound guidance. This prospective pilot study resulted in a highly significant achievement in pregnancy where 41 patients conceived out of 51 patients (80.39%) only 6 are in ongoing treatment. Those who didn’t seek fertility were 59 of which 43 have completed family 13 have one child and 3 unmarried girls. 96.61% were relieved of pain and recurrence and restored healthy sexual life, 2 are in ongoing treatment. We have not encountered any adverse effects during this treatment.